Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Full-length transcriptome and metabolite analysis reveal reticuline epimerase-independent pathways for benzylisoquinoline alkaloids biosynthesis in Sinomenium acutum
Ist Teil von
Frontiers in plant science, 2022-12, Vol.13, p.1086335-1086335
Ort / Verlag
Switzerland: Frontiers Media S.A
Erscheinungsjahr
2022
Quelle
EZB Electronic Journals Library
Beschreibungen/Notizen
Benzylisoquinoline alkaloids (BIAs) are a large family of plant natural products with important pharmaceutical applications.
is a medicinal plant from the Menispermaceae family and has been used to treat rheumatoid arthritis for hundreds of years.
contains more than 50 BIAs, and sinomenine is a representative BIA from this plant. Sinomenine was found to have preventive and curative effects on opioid dependence. Despite the broad applications of
, investigation on the biosynthetic pathways of BIAs from
is limited. In this study, we comprehensively analyzed the transcriptome data and BIAs in the root, stem, leaf, and seed of
. Metabolic analysis showed a noticeable difference in BIA contents in different tissues. Based on the study of the full-length transcriptome, differentially expressed genes, and weighted gene co-expression network, we proposed the biosynthetic pathways for a few BIAs from
, such as sinomenine, magnoflorine, and tetrahydropalmatine, and screened candidate genes involved in these biosynthesis processes. Notably, the reticuline epimerase (REPI/STORR), which converts (
)-reticuline to (
)-reticuline and plays an essential role in morphine and codeine biosynthesis, was not found in the transcriptome data of
. Our results shed light on the biogenesis of the BIAs in
and may pave the way for the future development of this important medicinal plant.